[1] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016[J]. CA Cancer J Clin, 2016, 66(1):7-30.
[2] Khamlichi S, Bailly P, Blanchard D, et al. Purification and partial characterization of the erythrocyte Kx protein deficient in McLeod patients[J]. Eur J Biochem,1995, 228(3):931-934.
[3] Jobb G, von Haeseler A, Strimmer K. TREEFINDER:a powerful graphical analysis environment for molecular phylogenetics[J]. BMC Evolutionary Biology, 2004, 4(1):1-8.
[4] Lee S, Russo D, Redman C M. The Kell blood group system: Kell and XK membrane proteins[J]. Semin Hematol, 2000, 37(2):113-121.
[5] Calenda G, Peng J, Redman C M, et al. Identification of two new members, XPLAC and XTES, of the XK family[J]. Gene, 2006, 70(3):6-16.
[6] Suzuki J, Imanishi E, Nagata S. Xkr8 phospholipid scrambling complex in apoptotic phosphatidylserine exposure[J]. Proc Natl Acad Sci U S A, 2016,113(34):9509-9514.
[7] Suzuki J, Imanishi E, Nagata S. Exposure of phosphatidylserine by Xk-related protein family members during apoptosis[J]. J Biol Chem, 2014, 289(44):30257-30267.
[8] Danek A, Rubio J P, Rampoldi L, et al. McLeod neuroacanthocytosis: Genotype and phenotype[J]. Ann Neurol, 2001,50(6):755-764. |